company? Let’s change
that.
Don't see your company?
Create a company profileGossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.
Genetics Squared is a biotechnology company that develops solutions for personalized medicines.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
Helping Make Research Possible We are helping make research possible by supplying scientists worldwide with the assay kits, antibodies, proteins, and biochemicals to advance their research. We know the scientific community needs more than our products, so our 100 in-house scientists, the same who design and develop our products, connect with researchers to answer questions, provide resources, and offer contract research services. We offer tools for diverse research areas, including cancer, inflammation, nitric oxide, neuroscience, epigenetics, diabetes, apoptosis, oxidative injury, endocrinology, atherosclerosis, and many more. We are also a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Accord Biomaterials, Inc. develops chemistries and coatings for medical device protection. It offers Nogen that are catalytic nitric oxide
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD).
Official LinkedIn page for Esperion. Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines accessible. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit esperion.com and follow us on Twitter at www.twitter.com/EsperionInc. Community guidelines: https://bit.ly/3vLCGdO
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
Accuri Cytometers is a medical device company developing cost effective cytometers for laboratories.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Swift Biosciences develops molecular biology reagents for research and diagnostic applications.
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
Work Your Passion. Live Your Purpose.